Breast Cancer Radiation Therapy

Although surgery is the first and most important step in the battle against cancer, it sometimes leaves a small number of infected cells in the breast, leaving the doors open for the disease to redevelop in the future. Radiation therapy, also known as radiotherapy, is a targeted and effective technique to destroy cancer cells that may have been missed during surgery. Radiotherapy reduces the risk of breast cancer recurrence by almost 70 percent. Compared to other treatments and techniques associated with breast cancer, radiation therapy is easier to tolerate as well as limited in its side effects.

How it works:

Breast cancer radiation therapy uses high-energy beams to target and destroy the DNA of infected cells so as to prevent them from multiplying. The radiated beam affects the DNA of all cells in its path – healthy as well as infected. But cancer cells are wild and less organized than healthy cells. While the healthy cells will be able to repair themselves and recuperate from the damage caused by the beam, the cancer cells are much more likely to die. Many people fear radiation therapy as the word conjures up images of mushroom clouds and green radioactive nuclear waste in their heads. However, therapeutic radiation is extremely controllable, focused and generally safe.

Why is it necessary?

Radiation is usually a necessary post-surgical procedure to reduce the risk of cancer recurrence. Although it is possible that the surgery was successful in removing all infected cells from your body, there is unfortunately no way to guarantee it as individual cells are not big enough to be detected through tests or during surgery. If a few such cells are left intact within the body, they would become detectable only when they have multiplied enough to form a small lump, by which time they will be a serious problem.

When is it necessary?

Radiation therapy has a vital role to play in the treatment of breast cancers of all stages. In comparison to other techniques associated with breast cancer treatment, radiotherapy is highly effective as well as safe. Specifically, the therapy is appropriate for women with breast cancers of stages I to III, after either lumpectomy or mastectomy. Radiation therapy also has a role to play in the treatment of stage IV cancer which has spread from the breast and lymph nodes to other parts of the body.

The side effects:

Once downside of breast cancer radiation therapy is that it tends to have some side effects, particularly on the skin of the area that is being treated. In most cases, the skin will react as it would to a sunburn. Ir might turn reddish, with burning, itching, soreness and perhaps peeling. With radiotherapy, unlike with sunburns, the skin will react to the radiation gradually and in nonuniform patches. After the conclusion of radiation therapy, the side effects on the skin will likely persist for another week or so before subsiding. During this period it is advisable to wear light, loose-fitting cotton clothes and to avoid irritating the treated area of skin as far as possible.

 

 

Alternative Cancer Treatments - Click Here

 

Breast Cancer News:

 

Oncology Care Live, Continuing Medical Education Congress Presented by the Johns Hopkins University School of Medicine .
Virtual Congress Led by Activity Directors Dr. Judith Karp and Dr. Luis Diaz to Review Latest Solid Tumor Treatments Live Video Presentations to Feature More than Thirty Cancer Care Leaders Over Two Days Registration Now Available at www.OncologyCareLive.com..


Britain's Breast Cancer Campaign launches first mobile giving .
The Breast Cancer Campaign claims the lead in breast cancer research in Britain and Ireland. Its mission is to fund research to understand the development of breast cancer, leading to better diagnosis, treatment, prevention and cure. ...


Lawmakers pass bill to restore breast cancer screenings | HealthyCal
Legislation that would reverse major cuts to a program that provides free mammograms for low-income women passed unanimously through the Senate Thursday and was sent to an uncertain fate in the office of Gov. Arnold Schwarzenegger...


Sheryl Crow - Crow Opens Breast Cancer Centre
Breast cancer survivor SHERYL CROW is opening a state-of-the art centre in Los Angeles to aid early detection of the deadly disease.Tuesday (24Aug10) marked the grand...


Movement to End Breast Cancer Continues at Tennessee State .
Movement to End Breast Cancer Continues at Tennessee State University. For the second year, Tennessee State University will host a stop on the Susan G. Komen For The Cure National Outreach Tour with the Komen on the Go mobile experience ...


FDA releases latest list of safety issues
The U.S. Food and Drug Administration has released its latest list of possible drug safety concerns, citing Roche's breast cancer drug Herceptin and Sanofi Aventis' heart drug Multaq, among others...


Breast Cancer: What is an EURearly StageEUR Breast Cancer | Care Our .
An EUREarly StageEUR breast cancer is sometimes referred as Stage 1 breast cancer. In such cases, the affected region is less than 2EUR2.5...


Cancer Survivor Sheryl Crow Opens Breast Cancer Center
Sheryl Crow Imaging Center is completed with the latest advancements in digital screening and diagnostic imaging technologies to aid early detection of cancer...


US FDA releases latest list of safety issues
* List cites drugs by Merck, Pfizer, Genentech, others..


Cancer Research
Cancer.The "C" word It's not a fun topic to tackle. Yet, what is promising is the amount of research being done to understand and fight cancer. On Three News First Edition, Doctor Anthony Lucci joined us to tell us more about his breast cancer research being done at the University of Texas M.D. Anderson Cancer Center right in our backyard in Houston...


A.M. Vitals: Latest J&J Recall Involves Two DePuy Hip Implants
Also: campaign donations by health insurers; Roche doesn't get an accelerated review of new breast-cancer drug; Obama administration touts Medicare anti-fraud efforts...


Alternative Treatments For Breast Cancer | Health For You
It is shocking to live with breast cancer statistics rising to 1 in 8 women developing some form of breast cancer in their lifetime. Women 50 and...


FDA Denies Priority Review For Roche Breast Cancer Drug : dBTechno
The drug was tested in breast cancer patients with a type of disease known as advanced HER2 positive breast cancer and in 1 third of patients, their tumors actually shrank when given the experimental drug. Priority review status is only ...


FDA Setback for Roche and Immunogen Breast Cancer Treatment .
The FDA denied accelerated approval of Roche's trastuzumab-DM1 (T-DM1) license application. T-DM1 is a potential breast cancer treatment. Roche will continue with its trials and plans a global regulatory submission in mid-2012...



 

 

Alternative Cancer Treatments - Click Here

 

Technorati Tags: , ,